Your AI-Trained Oncology Knowledge Connection!

Adam S. Feldman, MD, MPH

Articles by Adam S. Feldman, MD, MPH

POINT: Is Immediate Radical Cystectomy Justified When Non–Muscle-Invasive Bladder Cancer First Presents as High-Grade T1 Urothelial Carcinoma on Re-Resection?

ByAdam S. Feldman, MD, MPH

June 15th 2016

After a thorough repeat TURBT, disease control can be achieved with intravesical BCG and a bladder-sparing approach.

Latest Updated Articles

POINT: Is Immediate Radical Cystectomy Justified When Non–Muscle-Invasive Bladder Cancer First Presents as High-Grade T1 Urothelial Carcinoma on Re-Resection?
Published: June 15th 2016 | Updated:

Trending on CancerNetwork

FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC

FDA Grants Fast Track Designation to Novel PIK3α Inhibitor in Breast Cancer

Monitoring Response to Radioligand Therapy in Prostate Cancer

Tarlatamab May Offer New SOC for Relapsed ES-SCLC With Brain Metastases

KEYNOTE-B61 Trial Review

© 2025 MJH Life Sciences^®

All rights reserved.